慢性炎症性皮肤病患者中炎症性肠病的发生:一项队列研究
该队列研究利用美国全国性商业保险索赔数据,比较2004至2020年间皮肤科就诊的慢性炎症性皮肤病患者与无该病患者炎症性肠病发病率。中位随访718天,经倾向评分调整后,化脓性汗腺炎患者溃疡性结肠炎和克罗恩病风险均升高,银屑病患者仅克罗恩病风险升高,特应性皮炎、斑秃和白癜风患者风险未升高。
要点
- 化脓性汗腺炎患者溃疡性结肠炎(HR 2.30)和克罗恩病(HR 2.70)风险均升高。
- 银屑病患者仅克罗恩病风险升高(HR 1.23),溃疡性结肠炎风险未升高。
- 特应性皮炎、斑秃和白癜风患者炎症性肠病风险未升高。
核心结论
- 化脓性汗腺炎患者炎症性肠病风险升高,银屑病患者仅克罗恩病风险升高,特应性皮炎、斑秃和白癜风患者溃疡性结肠炎和克罗恩病风险均未升高。
研究设计与样本
- 基于美国全国性纵向商业保险索赔数据的队列研究,纳入2004至2020年皮肤科就诊的成人及儿童。
- 暴露组为诊断为银屑病、特应性皮炎、斑秃、白癜风或化脓性汗腺炎的患者,对照组为至少两次皮肤科就诊且未诊断慢性炎症性皮肤病的患者,通过风险集抽样选取。
- 随访至炎症性肠病诊断、死亡、退出保险或数据流结束,以先发生者为准;炎症性肠病事件通过验证算法(住院或内镜确诊)识别。
- 采用倾向评分十分位分层调整炎症性肠病危险因素后估算风险比(HR)及95%置信区间(CI)。
主要发现
- 共纳入特应性皮炎123 614例、银屑病83 049例、斑秃18 135例、白癜风9003例、化脓性汗腺炎6806例,以及无慢性炎症性皮肤病的对照2 376 120例。
- 中位随访718天,经倾向评分调整后,化脓性汗腺炎患者溃疡性结肠炎风险升高(HR 2.30,95% CI 1.61-3.28),克罗恩病风险升高(HR 2.70,95% CI 1.69-4.32)。
- 银屑病患者克罗恩病风险升高(HR 1.23,95% CI 1.03-1.46),溃疡性结肠炎风险未升高(HR 1.01,95% CI 0.89-1.14)。
- 特应性皮炎患者溃疡性结肠炎风险未升高(HR 1.02,95% CI 0.92-1.12),克罗恩病风险未升高(HR 1.08,95% CI 0.94-1.23)。
- 斑秃患者溃疡性结肠炎风险未升高(HR 1.18,95% CI 0.89-1.56),克罗恩病风险未升高(HR 1.26,95% CI 0.86-1.86);白癜风患者溃疡性结肠炎风险未升高(HR 1.14,95% CI 0.77-1.68),克罗恩病风险未升高(HR 1.45,95% CI 0.87-2.41)。
关键数值与推荐
- 化脓性汗腺炎患者溃疡性结肠炎HR 2.30(95% CI 1.61-3.28),克罗恩病HR 2.70(95% CI 1.69-4.32)。
- 银屑病患者克罗恩病HR 1.23(95% CI 1.03-1.46),溃疡性结肠炎HR 1.01(95% CI 0.89-1.14)。
- 特应性皮炎患者溃疡性结肠炎HR 1.02(95% CI 0.92-1.12),克罗恩病HR 1.08(95% CI 0.94-1.23)。
- 斑秃患者溃疡性结肠炎HR 1.18(95% CI 0.89-1.56),克罗恩病HR 1.26(95% CI 0.86-1.86)。
- 白癜风患者溃疡性结肠炎HR 1.14(95% CI 0.77-1.68),克罗恩病HR 1.45(95% CI 0.87-2.41)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several studies have linked various chronic inflammatory skin diseases (CISDs) with inflammatory bowel disease (IBD) in a range of data sources with mixed conclusions. OBJECTIVES: We compared the incidence of IBD - ulcerative colitis (UC) and Crohn disease (CD) - in patients with a CISD vs. similar persons without a CISD. METHODS: In this cohort study using nationwide, longitudinal, commercial insurance claims data from the USA, we identified adults and children who were seen by a dermatologist between 2004 and 2020, and diagnosed with either psoriasis, atopic dermatitis, alopecia areata, vitiligo or hidradenitis suppurativa. Comparator patients were identified through risk-set sampling; they were eligible if they were seen by a dermatologist at least twice and not diagnosed with a CISD. Patient follow-up lasted until either IBD diagnosis, death, disenrolment or end of data stream, whichever came first. IBD events, UC or CD, were identified via validated algorithms: hospitalization or diagnosis with endoscopic confirmation. Incidence rates were computed before and after adjustment via propensity-score decile stratification to account for IBD risk factors. Hazard ratios (HR) and 95% confidence intervals (CIs) were estimated to compare the incidence of IBD in CISD vs. non-CISD. RESULTS: We identified patients with atopic dermatitis (n = 123 614), psoriasis (n = 83 049), alopecia areata (n = 18 135), vitiligo (n = 9003) or hidradenitis suppurativa (n = 6806), and comparator patients without a CISD (n = 2 376 120). During a median follow-up time of 718 days, and after applying propensity-score adjustment for IBD risk factors, we observed increased risk of both UC (HRUC 2·30, 95% CI 1·61-3·28) and CD (HRCD 2·70, 1·69-4·32) in patients with hidradenitis suppurativa, an increased risk of CD (HRCD 1·23, 1·03-1·46) but not UC (HRUC 1·01, 0·89-1·14) in psoriasis, and no increased risk of IBD in atopic dermatitis (HRUC 1·02, 0·92-1·12; HRCD 1·08, 0·94-1·23), alopecia areata (HRUC 1·18, 0·89-1·56; HRCD 1·26, 0·86-1·86) or vitiligo (HRUC 1·14, 0·77-1·68; HRCD 1·45, 0·87-2·41). CONCLUSIONS: IBD was increased in patients with hidradenitis suppurativa. CD alone was increased in patients with psoriasis. Neither UC nor CD was increased in patients with atopic dermatitis, alopecia areata or vitiligo. What is already known about this topic? Several studies have linked various chronic inflammatory skin diseases (CISDs) with inflammatory bowel disease (IBD) utilizing a range of data sources, with mixed conclusions. What does this study add? This large-scale, claims-based cohort study expands current knowledge by providing background rates for IBD across multiple CISDs using consistent methods and within a single, nationally representative patient population. We observed a relative increased risk of IBD in patients with hidradenitis suppurativa, but the overall incidence rate difference of IBD was generally low. Crohn disease alone was significantly increased in patients with psoriasis, and neither ulcerative colitis nor Crohn disease was increased in patients with atopic dermatitis, vitiligo or alopecia areata.
引用
- Schneeweiss MC, Kirchgesner J, Wyss R, et al. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology. Br J Dermatol. 2022. PMID: 35718888. doi:10.1111/bjd.21704
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。